Neutrogena apologises after Hayden Panettiere’s death and postpartum claims
Developing story first seen 2 hours ago
Neutrogena has responded to mounting backlash following the death of actor Hayden Panettiere, acknowledging in an Instagram statement that it "made her feel unsupported during a very difficult time" and announcing plans to fund postpartum depression support services. The apology follows Panettiere's own account, detailed in her 2026 memoir and subsequent interviews, that the skincare brand had tried to end their near-decade partnership after she spoke publicly about her postpartum depression, allegedly citing a breach of her contract's "morals clause."
Panettiere said Neutrogena's attempt to drop her was blocked at the time by her representative, who told the company doing so would be illegal, though she believed the relationship was effectively over from then on. Her death, which triggered online calls for a boycott of Neutrogena, remains under investigation; police have reported no signs of foul play, though the US Drug Enforcement Administration has now joined the inquiry. Neutrogena said it would make "a significant investment" in a long-standing community health partner to widen women's access to postpartum depression care, with further details to be shared later.
- Neutrogena apologised, admitting it left Hayden Panettiere feeling unsupported
- Panettiere had alleged the firm tried to sack her over postpartum comments
- DEA has now joined the investigation into her death; no foul play signs found
New here? Start with this
Neutrogena is a skincare brand that had employed actor Hayden Panettiere, best known for her role in the TV series Heroes, as a spokesperson and brand ambassador for around a decade during her most prominent years in Hollywood. Panettiere later spoke openly about experiencing postpartum depression after the birth of her daughter, a condition that affects mood and wellbeing in some parents following childbirth.
Panettiere died recently, and the circumstances of her death are still being investigated by authorities, though police have said there is no indication of foul play so far. Following her death, attention turned to claims she had made in her 2026 memoir and in interviews, in which she said Neutrogena had tried to end their partnership after she discussed her postpartum depression publicly, citing a clause in her contract about personal conduct.
These claims prompted strong criticism of Neutrogena online, with some calling for a boycott of the brand, which led the company to issue a public statement responding to the situation. Its response, and the reaction to it, forms the latest stage of the story.
Both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
Advocates of the public backlash argue that Panettiere's own account, given in her memoir and interviews, described a powerful corporate partner threatening to end a lucrative decade-long relationship specifically because she spoke openly about postpartum depression, invoking a morals clause against her own vulnerability rather than supporting her. They contend that whether or not she was ultimately dropped that year, the chilling message to other women, especially those in the public eye who might otherwise speak candidly about maternal mental health, was real and damaging, and that public pressure, including calls for a boycott, is a legitimate and proportionate way to hold a major consumer brand accountable for how it treats those who represent it during a health crisis.
The case against
Those more sympathetic to Neutrogena would point out that the company did not, in fact, terminate the partnership that year, that its statement expressed genuine sadness and acknowledged Panettiere felt unsupported, and that it has committed to a concrete investment in postpartum depression support rather than merely offering words. They would caution against conflating a contested, one-sided allegation from years ago with the tragic and still-unexplained circumstances of her death, noting that police have found no signs of foul play and that a DEA-involved investigation is ongoing, meaning it is unfair and premature to hold the company morally responsible for an outcome whose causes remain unknown.
More coverage
- The Hollywood Reporter — Neutrogena Responds to Backlash in Wake of Onetime Ambassador Hayden Panettiere’s Death
- The Hollywood Reporter — Hayden Panettiere’s Boyfriend Breaks Silence on Her Death
Art Business Companies Culture
Read the full article at the source →
Originally published by Variety as “Neutrogena Comments on Hayden Panettiere’s Death Amid Backlash and Says ‘We Made Her Feel Unsupported’; Actor Said the Company Nearly Fired Her for Talking About Postpartum”.